{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T18:28:56Z","timestamp":1747852136367,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To develop a risk model based on dosimetric metrics to predict local recurrence in nasopharyngeal carcinoma (NPC) patients treated with intensive modulated radiation therapy (IMRT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>493 consecutive patients were included, among whom 44 were with local recurrence. One-to-two propensity score matching (PSM) was used to balance variables between recurrent and non-recurrent groups. Dosimetric metrics were extracted, and critical dosimetric predictors of local recurrence were identified by Cox regression model. Moreover, recurrent sites and patterns were examined by transferring the recurrent tumor to the pretreatment planning computed tomography.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After PSM, 44 recurrent and 88 non-recurrent patients were used for dosimetric analysis. The univariate analysis showed that eight dosimetric metrics and homogeneity index were significantly associated with local recurrence. The risk model integrating <jats:italic>D<\/jats:italic><jats:sub>5<\/jats:sub> and <jats:italic>D<\/jats:italic><jats:sub>95<\/jats:sub> achieved a C-index of 0.706 for predicting 3-year local recurrence free survival (LRFS). By grouping patients using median value of risk score, patients with risk score \u02c3 0.885 had significantly lower 3-year LRFS (66.2% vs. 86.4%, <jats:italic>p<\/jats:italic>\u2009=\u20090.023). As for recurrent features, the proportion of relapse in nasopharynx cavity, clivus, and pterygopalatine fossa was 61.4%, 52.3%, and 40.9%, respectively; and in field, marginal, and outside field recurrence constituted 68.2%, 20.5% and 11.3% of total recurrence, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The current study developed a novel risk model that could effectively predict the LRFS in NPC patients. Additionally, nasopharynx cavity, clivus, and pterygopalatine fossa were common recurrent sites and in field recurrence remained the major failure pattern of NPC in the IMRT era.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-021-01911-5","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T21:04:21Z","timestamp":1632431061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A novel dosimetric metrics-based risk model to predict local recurrence in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy"],"prefix":"10.1186","volume":"16","author":[{"given":"Wenjun","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maolang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2514-1614","authenticated-orcid":false,"given":"Jianghong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,23]]},"reference":[{"issue":"10192","key":"1911_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380. https:\/\/doi.org\/10.1016\/s0140-6736(19)30956-0.","journal-title":"Lancet"},{"key":"1911_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.semcancer.2019.09.006","volume":"61","author":"CM Tsang","year":"2020","unstructured":"Tsang CM, Lui VWY, Bruce JP, Pugh TJ, Lo KW. Translational genomics of nasopharyngeal cancer. Semin Cancer Biol. 2020;61:84\u2013100. https:\/\/doi.org\/10.1016\/j.semcancer.2019.09.006.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"1911_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ijrobp.2019.06.2549","volume":"105","author":"XS Sun","year":"2019","unstructured":"Sun XS, Liu SL, Luo MJ, et al. The association between the development of radiation therapy, image technology, and chemotherapy, and the survival of patients with nasopharyngeal carcinoma: a cohort study From 1990 to 2012. Int J Radiat Oncol, Biol, Phys. 2019;105(3):581\u201390. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.06.2549.","journal-title":"Int J Radiat Oncol, Biol, Phys"},{"issue":"1","key":"1911_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/s0360-3016(02)02724-4","volume":"53","author":"N Lee","year":"2002","unstructured":"Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol, Biol, Phys. 2002;53(1):12\u201322. https:\/\/doi.org\/10.1016\/s0360-3016(02)02724-4.","journal-title":"Int J Radiat Oncol, Biol, Phys"},{"issue":"22","key":"1911_CR5","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1002\/cncr.28934","volume":"120","author":"YM Tian","year":"2014","unstructured":"Tian YM, Zhao C, Guo Y, et al. Effect of total dose and fraction size on survival of patients with locally recurrent nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a phase 2, single-center, randomized controlled trial. Cancer. 2014;120(22):3502\u20139. https:\/\/doi.org\/10.1002\/cncr.28934.","journal-title":"Cancer"},{"key":"1911_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2019.101890","volume":"79","author":"AWM Lee","year":"2019","unstructured":"Lee AWM, Ng WT, Chan JYW, et al. Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev. 2019;79: 101890. https:\/\/doi.org\/10.1016\/j.ctrv.2019.101890.","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"1911_CR7","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/hed.25892","volume":"41","author":"WT Ng","year":"2019","unstructured":"Ng WT, Wong ECY, Cheung AKW, et al. Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT-A study by the HKNPCSG. Head Neck. 2019;41(10):3661\u20139. https:\/\/doi.org\/10.1002\/hed.25892.","journal-title":"Head Neck"},{"issue":"3","key":"1911_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/hed.24645","volume":"39","author":"OS Chan","year":"2017","unstructured":"Chan OS, Sze HC, Lee MC, et al. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma. Head Neck. 2017;39(3):533\u201340. https:\/\/doi.org\/10.1002\/hed.24645.","journal-title":"Head Neck"},{"issue":"3","key":"1911_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ijrobp.2019.06.2540","volume":"105","author":"AW Lee","year":"2019","unstructured":"Lee AW, Ng WT, Pan JJ, et al. International guideline on dose prioritization and acceptance criteria in radiation therapy planning for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2019;105(3):567\u201380. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.06.2540.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1911_CR10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.oraloncology.2014.01.017","volume":"50","author":"WT Ng","year":"2014","unstructured":"Ng WT, Lee MC, Chang AT, et al. The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT. Oral Oncol. 2014;50(5):506\u201312. https:\/\/doi.org\/10.1016\/j.oraloncology.2014.01.017.","journal-title":"Oral Oncol"},{"issue":"3","key":"1911_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/jjco\/hyx183","volume":"48","author":"F Xue","year":"2018","unstructured":"Xue F, Hu C, He X. Impact of minimum point dose on local control and toxicity in T3\u20134 nasopharyngeal carcinoma treated with intensity-modulated radiation therapy plus chemotherapy. Japan J Clin Oncol. 2018;48(3):265\u201371. https:\/\/doi.org\/10.1093\/jjco\/hyx183.","journal-title":"Japan J Clin Oncol"},{"key":"1911_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1748-717x-9-87","volume":"9","author":"JX Li","year":"2014","unstructured":"Li JX, Huang SM, Jiang XH, et al. Local failure patterns for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy. Radiat Oncol. 2014;9:87. https:\/\/doi.org\/10.1186\/1748-717x-9-87.","journal-title":"Radiat Oncol"},{"issue":"2","key":"1911_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/lary.26139","volume":"127","author":"JG Li","year":"2017","unstructured":"Li JG, Venigalla P, Leeman JE, et al. Patterns of nodal failure after intensity modulated radiotherapy for nasopharyngeal carcinoma. Laryngoscope. 2017;127(2):377\u201382. https:\/\/doi.org\/10.1002\/lary.26139.","journal-title":"Laryngoscope"},{"issue":"2","key":"1911_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ijrobp.2009.11.024","volume":"79","author":"WT Ng","year":"2011","unstructured":"Ng WT, Lee MC, Hung WM, et al. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol, Biol, Phys. 2011;79(2):420\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.11.024.","journal-title":"Int J Radiat Oncol, Biol, Phys"},{"issue":"12","key":"1911_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1177\/0003489417734229","volume":"126","author":"L Wang","year":"2017","unstructured":"Wang L, Guo Y, Xu J, et al. Clinical analysis of recurrence patterns in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Ann Otol Rhinol Laryngol. 2017;126(12):789\u201397. https:\/\/doi.org\/10.1177\/0003489417734229.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"1911_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00066-011-0015-x","volume":"188","author":"N Hodapp","year":"2012","unstructured":"Hodapp N. The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Onkol. 2012;188(1):97\u20139. https:\/\/doi.org\/10.1007\/s00066-011-0015-x.","journal-title":"Strahlenther Onkol"},{"issue":"22","key":"1911_CR17","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1200\/jco.2008.19.9109","volume":"27","author":"N Lee","year":"2009","unstructured":"Lee N, Harris J, Garden AS, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27(22):3684\u201390. https:\/\/doi.org\/10.1200\/jco.2008.19.9109.","journal-title":"J Clin Oncol"},{"key":"1911_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev.publhealth.21.1.121","volume":"21","author":"RJ Little","year":"2000","unstructured":"Little RJ, Rubin DB. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches. Annu Rev Pub Health. 2000;21:121\u201345. https:\/\/doi.org\/10.1146\/annurev.publhealth.21.1.121.","journal-title":"Annu Rev Pub Health"},{"issue":"8","key":"1911_CR19","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med phys. 2010;37(8):4078\u2013101. https:\/\/doi.org\/10.1118\/1.3438081.","journal-title":"Med phys"},{"issue":"5","key":"1911_CR20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/s0360-3016(99)00550-7","volume":"46","author":"LA Dawson","year":"2000","unstructured":"Dawson LA, Anzai Y, Marsh L, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46(5):1117\u201326. https:\/\/doi.org\/10.1016\/s0360-3016(99)00550-7.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1911_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ijrobp.2010.03.024","volume":"80","author":"SZ Lai","year":"2011","unstructured":"Lai SZ, Li WF, Chen L, et al. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys. 2011;80(3):661\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.03.024.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1911_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ijrobp.2010.09.011","volume":"82","author":"SF Su","year":"2012","unstructured":"Su SF, Han F, Zhao C, et al. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone. Int J Radiat Oncol Biol Phys. 2012;82(1):327\u201333. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.09.011.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1911_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijrobp.2005.03.057","volume":"64","author":"SL Wolden","year":"2006","unstructured":"Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006;64(1):57\u201362. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.03.057.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1911_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","volume":"104","author":"G Peng","year":"2012","unstructured":"Peng G, Wang T, Yang KY, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012;104(3):286\u201393. https:\/\/doi.org\/10.1016\/j.radonc.2012.08.013.","journal-title":"Radiother Oncol"},{"issue":"11","key":"1911_CR25","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.oraloncology.2015.08.005","volume":"51","author":"B Zhang","year":"2015","unstructured":"Zhang B, Mo Z, Du W, Wang Y, Liu L, Wei Y. Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: a systematic review and meta-analysis. Oral Oncol. 2015;51(11):1041\u20136. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.08.005.","journal-title":"Oral Oncol"},{"issue":"2","key":"1911_CR26","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1016\/j.prro.2016.11.003","volume":"7","author":"IJ Das","year":"2017","unstructured":"Das IJ, Andersen A, Chen ZJ, et al. State of dose prescription and compliance to international standard (ICRU-83) in intensity modulated radiation therapy among academic institutions. Pract Radiat Oncol. 2017;7(2):e145\u201355. https:\/\/doi.org\/10.1016\/j.prro.2016.11.003.","journal-title":"Pract Radiat Oncol"},{"key":"1911_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.radonc.2019.09.001","volume":"141","author":"J Wang","year":"2019","unstructured":"Wang J, Qing G, Ou X, Hu W, Hu C, Zhang Z. The impact of target dosimetry on patients\u2019 locoregional recurrence in nasopharyngeal carcinoma: a propensity score-matched analysis. Radiother Oncol. 2019;141:67\u201371. https:\/\/doi.org\/10.1016\/j.radonc.2019.09.001.","journal-title":"Radiother Oncol"},{"issue":"1","key":"1911_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.rpor.2019.12.012","volume":"25","author":"W Mnejja","year":"2020","unstructured":"Mnejja W, Daoud H, Fourati N, et al. Dosimetric impact on changes in target volumes during intensity-modulated radiotherapy for nasopharyngeal carcinoma. Rep Pract Oncol Radiother. 2020;25(1):41\u20135. https:\/\/doi.org\/10.1016\/j.rpor.2019.12.012.","journal-title":"Rep Pract Oncol Radiother"},{"key":"1911_CR29","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.2147\/ott.s53639","volume":"6","author":"W Tan","year":"2013","unstructured":"Tan W, Li Y, Han G, et al. Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Onco Targets Ther. 2013;6:1719\u201328. https:\/\/doi.org\/10.2147\/ott.s53639.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"1911_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.meddos.2009.06.007","volume":"35","author":"X Wang","year":"2010","unstructured":"Wang X, Lu J, Xiong X, et al. Anatomic and dosimetric changes during the treatment course of intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma. Med Dosim. 2010;35(2):151\u20137. https:\/\/doi.org\/10.1016\/j.meddos.2009.06.007.","journal-title":"Med Dosim"},{"issue":"7","key":"1911_CR31","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.7150\/jca.39588","volume":"11","author":"X Yang","year":"2020","unstructured":"Yang X, Ren H, Yu W, et al. Analysis of clinical target volume delineation in local-regional failure of nasopharyngeal carcinoma after intensity-modulated radiotherapy. J Cancer. 2020;11(7):1968\u201375. https:\/\/doi.org\/10.7150\/jca.39588.","journal-title":"J Cancer"},{"issue":"3","key":"1911_CR32","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ijrobp.2018.10.006","volume":"103","author":"NN Sanford","year":"2019","unstructured":"Sanford NN, Lau J, Lam MB, et al. Individualization of clinical target volume delineation based on stepwise spread of nasopharyngeal carcinoma: outcome of more than a decade of clinical experience. Int J Radiat Oncol Biol Phys. 2019;103(3):654\u201368. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.10.006.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01911-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-021-01911-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01911-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T21:24:06Z","timestamp":1632432246000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-021-01911-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,23]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1186\/s13014-021-01911-5","relation":{},"ISSN":["1748-717X"],"issn-type":[{"type":"electronic","value":"1748-717X"}],"subject":[],"published":{"date-parts":[[2021,9,23]]},"assertion":[{"value":"12 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee on Biomedical Research of the West China Hospital and the informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}